Crohn's disease trials in Italy
52 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleStudy of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Where
- Catanzaro, Messina, Milan, Monserrato, Negrar, Rome, Rozzano, San Giovanni Rotondo, Turin
- Age
- 18 years to 75 years
- People
- 590 worldwide
- Run by
- AbbVie
See details and how to joinNCT06548542 · EU 2024-513009-30-00 - No phaseNot yet taking people in ItalyDevelopment of the SC-IBD Self-Care Measurement Scale
- Where
- Roma
- Age
- 18 years and over
- People
- 275
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07494227 - No phaseNot yet taking people in ItalyEx Vivo Comparison Of Combination Versus Single Therapeutic Pathway Inhibition In Human Intestinal Mucosa From Patients With Inflammatory Bowel Disease
- Where
- Milan
- Age
- 18 years and over
- People
- 30
- Run by
- PhoenixLAB srls
See details and how to joinNCT07824726 - Phase 1/2Taking peopleClostridium Butyricum in Stenosing Crohn's Disease
- Where
- Roma
- Age
- 18 years to 85 years
- People
- 40
- Run by
- San Giovanni Addolorata Hospital
See details and how to joinNCT07263880 - No phaseTaking peopleComparison Between Artificial Intelligence and Standard Reading to Investigate Suspected Crohn Disease: the SCAI STUDY
- Where
- Brescia
- Age
- 18 years to 75 years
- People
- 180
- Run by
- Fondazione Poliambulanza Istituto Ospedaliero
See details and how to joinNCT07111715 - Phase 3Taking peopleCrohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year
- Where
- Bologna, Bolzano, Catania, Genoa, Milan, Rome, Rozzano, Turin
- Age
- 18 years and over
- People
- 302 worldwide
- Run by
- Janssen Cilag International
See details and how to join2025-521590-13-00 · EU 2025-521590-13-00 - Phase 3Taking peopleA Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Where
- Messina, Milan, Pescara, Rome
- Age
- 2 years to 17 years
- People
- 70 worldwide
- Run by
- Takeda
See details and how to joinNCT06100289 · EU 2023-503188-40-00 - No phaseNot yet taking people in ItalyTOLerogenic Potential of Hematopoietic Stem and Progenitor Cells and Inflammatory Bowel Disease
- Where
- Milan, Rome
- Age
- 2 years to 18 years
- People
- 80
- Run by
- IRCCS San Raffaele
See details and how to joinNCT07740499 - No phaseTaking peopleProspective Risk Evaluation and Detection of Crohn's Disease in First-degree Relatives
- Where
- Roma
- Age
- 16 years to 35 years
- People
- 10,000 worldwide
- Run by
- GLSMED Learning Health S.A.
See details and how to joinNCT07316621 - No phaseTaking peopleA Specific Probiotic in thE MOdulation of Gut Microbiota of patieNts With Mild-to-modErate Ulcerative Colitis
- Where
- Roma
- Age
- 18 years to 80 years
- People
- 20
- Run by
- Catholic University of the Sacred Heart
See details and how to joinNCT07724990 - No phaseTaking peopleEvaluation of the Accuracy of Immunostaining of Claudin 2 to Detect Active or Inactive Inflammation in Endoscopic Biopsies of IBD
- Where
- San Donato Milanese
- Age
- 18 years and over
- People
- 100
- Run by
- IRCCS Policlinico S. Donato
See details and how to joinNCT07710287 - No phaseTaking peopleResting Energy Expenditure in Pediatric Patients With Inflammatory Bowel Disease (REE-MICI)
- Where
- Alessandria
- Age
- 6 years to 17 years
- People
- 50
- Run by
- Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
See details and how to joinNCT07670975 - No phaseTaking peoplePartial Enteral Nutrition to Prevent Weight Loss and Sarcopenia in IBD Patients at Nutritional Risk - SIMBA
- Where
- Naples, Pavia, Roma, Rozzano
- Age
- 18 years to 65 years
- People
- 146
- Run by
- Lionhealth Srl Società Benefit
See details and how to joinNCT07433946 - No phaseTaking peopleA Study to Assess the Effectiveness of Second-Line Therapy of Upadacitinib and Risankizumab in Adult Participants With Crohn's Disease in a Real-World Setting
- Where
- Bari, Bologna, Cagliari, Castellana Grotte, Catania, Catanzaro, Genova, Milan, Monserrato, Monza, Naples, Negrar, Palermo, Pescara, Roma, Rome, Rozzano, San Giovanni Rotondo, Turin
- Age
- 18 years and over
- People
- 250
- Run by
- AbbVie
See details and how to joinNCT07073079 - Phase 3Taking peopleA Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- Where
- Cagliari, Milan, Naples, Padova, Rome, Rozzano, San Giovanni Rotondo, Turin
- Age
- 18 years to 65 years
- People
- 396 worldwide
- Run by
- Takeda
See details and how to joinNCT06227910 · EU 2023-509391-42-00 - Phase 2Taking peopleA Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- Where
- Bologna, Milan, Palermo, Rome, Rozzano
- Age
- 18 years to 75 years
- People
- 192 worldwide
- Run by
- Takeda
See details and how to joinNCT06764615 · EU 2024-518914-18-00 - No phaseTaking peopleStudy of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis
- Where
- Florence, Naples, Rozzano
- Age
- 18 years to 90 years
- People
- 600 worldwide
- Run by
- Weill Medical College of Cornell University
See details and how to joinNCT03256240 - Phase 3Taking peopleA Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Where
- Bologna, Florence, Monza, Naples, Rome
- Age
- 2 years to 17 years
- People
- 240 worldwide
- Run by
- Takeda
See details and how to joinNCT05442567 · EU 2023-509046-36-00 - Phase 3Taking peopleA Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Where
- Bologna, Florence, Naples, Rome
- Age
- 2 years to 17 years
- People
- 120 worldwide
- Run by
- Takeda
See details and how to joinNCT04779320 · EU 2023-509045-13-00 - Phase 4Taking peoplePrevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy
- Where
- Castellana Grotte, Florence, Milan
- Age
- 18 years to 80 years
- People
- 292 worldwide
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT05169593 - Phase 2Taking peopleEfficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Where
- Bologna, Catanzaro, Milan, Negrar, Pavia, Rome, Rozzano, San Giovanni Rotondo
- Age
- 18 years to 75 years
- People
- 212 worldwide
- Run by
- Abivax S.A.
See details and how to joinNCT06456593 · EU 2023-508234-34-00 - No phaseTaking peopleImpact of Exclusion Diet in Addition to Anti-TNF Therapy in Crohn's Disease and Ulcerative Colitis: a Prospective, Randomized, Double-arm, Open-label Study
- Where
- Milan
- Age
- 18 years and over
- People
- 80
- Run by
- IRCCS Ospedale San Raffaele
See details and how to joinNCT06896305 - Phase 4Taking peopleVECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
- Where
- Bologna, Milan, Rome, Rozzano, San Giovanni Rotondo
- Age
- 18 years to 80 years
- People
- 304 worldwide
- Run by
- Alimentiv Inc.
See details and how to joinNCT06257706 · EU 2023-509096-16-00 - No phaseTaking peopleSpatially and Temporally Resolving Predictive Biomarkers of Postoperative Recurrence and Complications in Chronic Intestinal Inflammation
- Where
- Milan
- Age
- 18 years to 69 years
- People
- 35
- Run by
- IRCCS Ospedale San Raffaele
See details and how to joinNCT06516341 - No phaseTaking peopleStudy on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-mediated Inflammatory Pathology. Observational Multicenter Study.
- Where
- Florence, Foggia, Palermo, Roma
- People
- 90
- Run by
- Meyer Children's Hospital IRCCS
See details and how to joinNCT06862843